Algo version: 0.98b
Lasa Supergenerics is listed at the NSE Exchange
Lasa Supergenerics [LASA.NS]
NSE Sector: Healthcare Industry:Drug Manufacturers—Specialty & Generic

Is Lasa Supergenerics stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

Yes, Lasa Supergenerics pays dividends. Last time was Wednesday 26th of October 2022 where the investors holding the stock on Friday 16th of September 2022 were paid INR0.25 per share. Over the last 2 times between 2021 and 2022, Lasa Supergenerics has paid INR0.5 with an average of INR0.25 per share.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Lasa Supergenerics 10 years ago, but if you had invested on Monday 9th of September 2019 when the price was INR15.10, you would have made a profit of INR16.54 per share or 109.54%

Yes, the average daily trading liquidity for Lasa Supergenerics is INR171 102 thousand. You should therefore be able to get in and out of your positions relatively fast.

Lasa Supergenerics has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. With a high cash flow to debt ratio of 1.10, the company's ability to pay off the debt is good. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.

We have calculated the inflation risk for Lasa Supergenerics to be medium [0.55 of 1]

US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.